Kopelovich L
Department of Cancer Genetics and Cancer Prevention, VA Medical Center, Bay Pines, FL 33504.
Mutat Res. 1988 Jun;199(2):369-85. doi: 10.1016/0027-5107(88)90215-1.
The present study demonstrated the expression of abnormal phenotypes (biomarkers) in cultured skin fibroblasts from hereditary adenomatosis of the colon and rectum (ACR) and neurofibromatosis (NF) patients. These biomarkers occur systemically and they include cytoskeletal structures, cytotoxicity and sensitivity to transformation by oncogenic agents, expression of transformation-associated antigen, and effects by a tumor promoter. Collectively, these biomarkers define the transformed (initiated) human cell phenotype, as determined through use of cultured skin fibroblasts that were obtained from individuals at risk of cancer. In conjunction with clinical signs, these biomarkers can be used to determine gene expression and gene penetrance. Extension of these studies in the form of a multiparameter matrix may permit the early detection of cancer.
本研究证明了遗传性结肠直肠癌(ACR)和神经纤维瘤病(NF)患者培养的皮肤成纤维细胞中异常表型(生物标志物)的表达。这些生物标志物在全身出现,包括细胞骨架结构、细胞毒性和对致癌剂转化的敏感性、转化相关抗原的表达以及肿瘤启动子的作用。总体而言,这些生物标志物定义了转化(起始)的人类细胞表型,这是通过使用从有癌症风险的个体获得的培养皮肤成纤维细胞确定的。结合临床体征,这些生物标志物可用于确定基因表达和基因外显率。以多参数矩阵形式扩展这些研究可能有助于癌症的早期检测。